期刊文献+

小儿社区获得性肺炎住院时间的影响因素分析 被引量:2

下载PDF
导出
摘要 目的分析小儿社区获得性肺炎的病情资料,了解影响其住院时间的相关因素.方法在2011年至2014年区间内,以年份为变量,分层抽取患儿资料,共计800例.制作数据采集表收集全部患儿的一般情况、发病经过、相关检查及治疗方案等相关信息.结果全部患儿中,最短住院Id,最长39d,中位数是8d(P25=7,P75=9)D治疗结局不同患儿的平均住院时间具有显著的统计学差异(P 〈0.001)DCox风险比例分析结果表明,患儿早出院的出现率方面,在治疗效果显著的患者中,应用炎琥宁的患儿是应用喜炎平患儿的0.42倍(95°%CI:0.28-0.64),应用单磷酸腺苷的患儿是应用喜炎平患者的0.38倍(95°%CI:0.24-0.60);但在病情好转的患儿中,应用炎琥宁的患儿是应用喜炎平患儿的0.48倍(95°%CI:0.23-0.99).结论小儿社区获得性肺炎的住院时间会受到人口因素、临床症状和治疗方案的多方面影响,临床工作中好需要医生结合患儿的个体情况仔细辨别比较并制定相应的治疗方案.
作者 蒲荣
出处 《生物技术世界》 2015年第9期80-81,共2页 Biotech World
  • 相关文献

参考文献5

  • 1Walker CL, R udan I,Liu L,et a l . Global burden of childhoodpneumonia and diarrhoea [J]. Lancet,2013,381(9875):1405-1416.
  • 2Madhi SA,De Wals P,Grijalva CG,et al.The burden of childhoodpneumonia in the developed world: a review of the literature[J].Pediatr Infect Dis J ,2013,32(3) : e 1 1 9 - 1 2 7 .
  • 3Nascimento Carvalho CM,Madhi SA,O " Brien KL. R eview ofguidelines for evidence-based management for childhood community-acquired pneumonia in under- 5 years from developedand developing countries[J]Pediatr Infect Dis J ,2013,32(1 1):1 2 8 1 - 1 2 8 2 .
  • 4陈光福,胡元生,沈继龙,石杜鹃,刘丽丽,李若梅,汪学龙,温和.社区获得性肺炎的病原体调查与药物敏感性分析[J].中华疾病控制杂志,2009,13(3):273-276. 被引量:17
  • 5彭永圣.喜炎平与炎琥宁对小儿急性支气管炎患者临床疗效分析[J].海峡药学,2013,25(5):224-225. 被引量:17

二级参考文献22

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3041
  • 2Wcllinghausen N, Straube E, Freidank H, et al. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia [J]. Int J Med Microbiol, 2006,296(7) :485-491.
  • 3Kashyap B, Kumar S, Sethi GR, et al. Comparison of PCR, culture & serological tests for the diagnosis of Mycoplasma pneumoniae in community acquired lower respiratory tract infections in children [J]. Indian J Med Res, 2008,128(2):134-139.
  • 4Ito T, Iijima M, Fukushima T, et al. Pediatric pneumonia death caused by community-acquired rnethicillin-resistant Staphylococcus aureus, Japan [J]. Emerg Infect Dis, 2008,14(8) :1312-1314.
  • 5Durrington HJ, Summers C. Recent changes in the management of community acquired pneumonia in adults [J]. BMC, 2008,336 (7658) : 1429-1433.
  • 6Daxboeck N, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection [J]. Clin microbiol Infect, 2003,9(4):263-273.
  • 7Miyashita N, Saito A, Kohno S, et al. Multiplex PCR for the simultaneous detection of Chlamydia pncumoniae, Mycoplasma pneumoniac and Legionella pneumophila in community-acquired pneumonia [J]. Respir Med, 2004,98(6) : 542-550.
  • 8Deng J, Zheng Y, Zhao R, et al. Culture versus polymerase chain reaction for the etiologic diagnosis of community-acquired pneumonia in antibiotic-pretreated pediatric patients [J]. Pediatr Infect Dis J, 2009.28( 1 ) :53-55.
  • 9Loens K, Beck T, Ursi D, et al. Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionclla spp. in respiratory specimens from patients with community-acquired pneurgonia [ J ]. J Microbiol Methods, 2008,73(3) :257-262.
  • 10Speich R, Schneider S, Hofer M, et al. Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation[ J . Pulm Pharmacol T- her,2010,23 (5) :445-446.

共引文献31

同被引文献29

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部